Research | OneLook Acronym Finder |
Serial Number | 87540379 |
Registration Number | 5854175 |
Mark Drawing Code | 3000: Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) |
Attorney Name | Daniel I. Schloss |
Attorney Docket Number | 174483.01010 |
Law Office Assigned | M30 |
Employee Name | PERRY, KIMBERLY B |
2017-07-24 | Application Filed |
2019-01-08 | Location: TMO LAW OFFICE 112 - EXAMINING ATTORNEY ASSIGNED |
2019-01-08 | Status: Live/Pending |
2019-01-08 | Transaction Date |
2019-06-25 | Published for Opposition |
2019-09-10 | Trademark Registered |
Owner: | Boryung Holdings Co., Ltd. |
Address | 136, Changgyeonggung-ro, Jongno-gu Seoul KR 03127 |
Legal Entity Type | Corporation |
Legal Entity State | KR |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
260913 | Squares, exactly two squares; Two squares |
260921 | Squares that are completely or partially shaded |
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | Pharmaceuticals for hypertension prevention; Pharmaceutical preparations acting on nervous system; medicines for sensory organs, namely, pharmaceutical preparations for the treatment and prevention of disorders of sensory organs; allergy medications; pharmaceutical preparations for the treatment of cardiovascular system related diseases and disorders; pharmaceutical preparations for treating respiratory organs diseases; pharmaceutical preparations acting on digestive organs for treating digestive diseases; pharmaceutical preparations for urogenital organs for treating urogenital diseases; vitamin preparations; pharmaceutical preparations for endocrine systems for the treatment of endocrine-related diseases and disorders; pharmaceutical preparations for tumor treatment; antibiotic preparations for medical purposes; biological preparations for medical purposes for the treatment of diseases and disorders of the sensory organs, cardiovascular system, digestive organs, urogenital organs, and endocrine system, and for the treatment of allergies and tumors; antifungal preparations for medical purposes; pharmaceutical preparations for cell therapy; Pharmaceutical preparations for the treatment of leukemia; Nutraceuticals for use as dietary supplements |
CC0000 | The color(s) red, blue, and black is/are claimed as a feature of the mark. |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2017-07-27 | 1 NWAP I:Incoming Correspondence |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2017-07-29 | 2 NWOS I:Incoming Correspondence |
NOTICE OF DESIGN SEARCH CODE E-MAILED | 2017-08-01 | 3 MDSC E:E-Mail |
TEAS VOLUNTARY AMENDMENT RECEIVED | 2017-08-08 | 4 PARI I:Incoming Correspondence |
ASSIGNED TO LIE | 2017-08-27 | 5 ALIE A:Allowance for Publication |
APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED | 2017-09-02 | 6 AMPX O:Outgoing Correspondence |
ASSIGNED TO EXAMINER | 2017-10-23 | 7 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2017-10-31 | 8 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2017-10-31 | 9 GNRT F:First Action |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2017-10-31 | 10 GNRN O:Outgoing Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2018-04-19 | 11 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2018-04-19 | 12 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2018-04-20 | 13 TEME I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2018-05-07 | 14 CNSA P: |
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | 2018-05-11 | 15 ERRR O:Outgoing Correspondence |
PREVIOUS ALLOWANCE COUNT WITHDRAWN | 2018-05-15 | 16 ZZZX Z:Deletion |
SUSPENSION LETTER WRITTEN | 2018-05-15 | 17 CNSL R:Renewal |
LETTER OF SUSPENSION E-MAILED | 2018-05-15 | 18 GNSL S: |
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2018-05-15 | 19 GNS3 O:Outgoing Correspondence |
LIE CHECKED SUSP - TO ATTY FOR ACTION | 2018-12-06 | 20 RCCK S: |
SUSPENSION INQUIRY WRITTEN | 2019-01-08 | 21 CNSI R:Renewal |
INQUIRY TO SUSPENSION E-MAILED | 2019-01-08 | 22 GNSI S: |
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | 2019-01-08 | 23 GNS2 O:Outgoing Correspondence |
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 2019-05-10 | 24 ERSI I:Incoming Correspondence |
ELECTRONIC RECORD REVIEW COMPLETE | 2019-05-14 | 25 FIXD O:Outgoing Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-05-14 | 26 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-05-14 | 27 TEME I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-05-22 | 28 CNSA O:Outgoing Correspondence |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-06-05 | 29 NONP E:E-Mail |
PUBLISHED FOR OPPOSITION | 2019-06-25 | 30 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-06-25 | 31 NPUB E:E-Mail |
REGISTERED-PRINCIPAL REGISTER | 2019-09-10 | 32 R.PR A:Allowance for Publication |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.